PTPN1 and obesity disorder: The ability of PTP-1B to negatively regulate insulin receptor kinase has been established at the molecular level [15] and the ablation of the PTP-1B gene yields mice displaying characteristics which suggest that inhibition of PTP-1B function may be an effective strategy for the treatment of diabetes and obesity during aging [11,13].